{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zahra FT"],"funding":["FDA's Perinatal Health Center of Excellence","NICHD NIH HHS","FDA’s Perinatal Health Center of Excellence","NHLBI","NHLBI NIH HHS","NICHD","NIH","NIH HHS"],"pagination":["1645-1648"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9047211"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["75(9)"],"pubmed_abstract":["Our study demonstrates that children who developed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination-induced myocarditis and may not receive another vaccination, could be susceptible to infection with Omicron and emerging variants. We observed higher neutralizing antibody titers in myocarditis patients vs. healthy vaccinated children, but significantly lower neutralization titers against Omicron in both groups."],"journal":["Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"],"pubmed_title":["Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron and Other Variants in Serum From Children With Vaccination-Induced Myocarditis."],"pmcid":["PMC9047211"],"funding_grant_id":["1RO1 HL140898","OCET 2021-1565","3U24HL135691-03S3","number GCBER005","1R61HD105590"],"pubmed_authors":["Dummer K","Tremoulet AH","Grubbs G","Burns JC","Shimizu C","Zahra FT","Khurana S"],"additional_accession":[]},"is_claimable":false,"name":"Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron and Other Variants in Serum From Children With Vaccination-Induced Myocarditis.","description":"Our study demonstrates that children who developed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination-induced myocarditis and may not receive another vaccination, could be susceptible to infection with Omicron and emerging variants. We observed higher neutralizing antibody titers in myocarditis patients vs. healthy vaccinated children, but significantly lower neutralization titers against Omicron in both groups.","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Oct","modification":"2025-04-25T22:56:56.819Z","creation":"2025-02-19T03:59:02.042Z"},"accession":"S-EPMC9047211","cross_references":{"pubmed":["35445250"],"doi":["10.1093/cid/ciac323"]}}